Cheyne Capital Management (UK)’s MoonLake Immunotherapeutics MLTX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2023
Q1
Sell
-32,129
Closed -$337K 37
2022
Q4
$337K Buy
+32,129
New +$337K 0.59% 44